Suppr超能文献

人胚胎干细胞来源的视网膜类器官与视网膜色素上皮细胞的共移植用于免疫缺陷视网膜退化的皇家外科学院大鼠的视网膜重建

Co-grafts of Human Embryonic Stem Cell Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons Rats.

作者信息

Thomas Biju B, Lin Bin, Martinez-Camarillo Juan Carlos, Zhu Danhong, McLelland Bryce T, Nistor Gabriel, Keirstead Hans S, Humayun Mark S, Seiler Magdalene J

机构信息

Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, United States.

USC Ginsburg Institute for Biomedical Therapeutics, University of Southern California, Los Angeles, CA, United States.

出版信息

Front Neurosci. 2021 Oct 26;15:752958. doi: 10.3389/fnins.2021.752958. eCollection 2021.

Abstract

End-stage age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are two major retinal degenerative (RD) conditions that result in irreversible vision loss. Permanent eye damage can also occur in battlefields or due to accidents. This suggests there is an unmet need for developing effective strategies for treating permanent retinal damages. In previous studies, co-grafted sheets of fetal retina with its retinal pigment epithelium (RPE) have demonstrated vision improvement in rat retinal disease models and in patients, but this has not yet been attempted with stem-cell derived tissue. Here we demonstrate a cellular therapy for irreversible retinal eye injuries using a "total retina patch" consisting of retinal photoreceptor progenitor sheets and healthy RPE cells on an artificial Bruch's membrane (BM). For this, retina organoids (ROs) (cultured in suspension) and polarized RPE sheets (cultured on an ultrathin parylene substrate) were made into a co-graft using bio-adhesives [gelatin, growth factor-reduced matrigel, and medium viscosity (MVG) alginate]. transplantation experiments were conducted in immunodeficient Royal College of Surgeons (RCS) rats at advanced stages of retinal degeneration. Structural reconstruction of the severely damaged retina was observed based on histological assessments and optical coherence tomography (OCT) imaging. Visual functional assessments were conducted by optokinetic behavioral testing and superior colliculus electrophysiology. Long-term survival of the co-graft in the rat subretinal space and improvement in visual function were observed. Immunohistochemistry showed that co-grafts grew, generated new photoreceptors and developed neuronal processes that were integrated into the host retina. This novel approach can be considered as a new therapy for complete replacement of a degenerated retina.

摘要

晚期年龄相关性黄斑变性(AMD)和视网膜色素变性(RP)是导致不可逆视力丧失的两种主要视网膜退行性疾病(RD)。永久性眼损伤也可能发生在战场或因意外事故导致。这表明开发治疗永久性视网膜损伤的有效策略存在未满足的需求。在先前的研究中,将胎儿视网膜与其视网膜色素上皮(RPE)共同移植的薄片已在大鼠视网膜疾病模型和患者中显示出视力改善,但尚未尝试使用干细胞衍生组织进行此操作。在这里,我们展示了一种针对不可逆视网膜眼损伤的细胞疗法,该疗法使用由视网膜光感受器祖细胞薄片和人工布鲁赫膜(BM)上的健康RPE细胞组成的“全视网膜贴片”。为此,使用生物粘合剂[明胶、生长因子减少的基质胶和中等粘度(MVG)海藻酸盐]将视网膜类器官(ROs)(悬浮培养)和极化的RPE薄片(在超薄聚对二甲苯底物上培养)制成共同移植物。在视网膜变性晚期的免疫缺陷皇家外科医学院(RCS)大鼠中进行了移植实验。基于组织学评估和光学相干断层扫描(OCT)成像观察了严重受损视网膜的结构重建。通过视动行为测试和上丘电生理学进行视觉功能评估。观察到共同移植物在大鼠视网膜下间隙的长期存活和视觉功能的改善。免疫组织化学显示共同移植物生长、产生新的光感受器并发育出整合到宿主视网膜中的神经突。这种新方法可被视为一种完全替代退化视网膜的新疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c52/8576198/3cb0d6683c49/fnins-15-752958-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验